These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11786280)
1. Novel chelating agents for potential clinical applications of copper. Ma D; Lu F; Overstreet T; Milenic DE; Brechbiel MW Nucl Med Biol; 2002 Jan; 29(1):91-105. PubMed ID: 11786280 [TBL] [Abstract][Full Text] [Related]
2. Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditions. Planalp RP; Przyborowska AM; Park G; Ye N; Lu FH; Rogers RD; Broker GA; Torti SV; Brechbiel MW Biochem Soc Trans; 2002 Aug; 30(4):758-62. PubMed ID: 12196188 [TBL] [Abstract][Full Text] [Related]
3. Nickel(II), copper(II) and zinc(II) binding properties and cytotoxicity of tripodal, hexadentate tris(ethylenediamine)--analogue chelators. Ye N; Park G; Przyborowska AM; Sloan PE; Clifford T; Bauer CB; Broker GA; Rogers RD; Ma R; Torti SV; Brechbiel MW; Planalp RP Dalton Trans; 2004 May; (9):1304-11. PubMed ID: 15252622 [TBL] [Abstract][Full Text] [Related]
4. Tailoring the local environment around metal ions: a solution chemical and structural study of some multidentate tripodal ligands. Matyuska F; Szorcsik A; May NV; Dancs Á; Kováts É; Bényei A; Gajda T Dalton Trans; 2017 Jul; 46(26):8626-8642. PubMed ID: 28650056 [TBL] [Abstract][Full Text] [Related]
5. N-picolyl derivatives of Kemp's triamine as potential antitumor agents: a preliminary investigation. Regino CA; Torti SV; Ma R; Yap GP; Kreisel KA; Torti FM; Planalp RP; Brechbiel MW J Med Chem; 2005 Dec; 48(25):7993-9. PubMed ID: 16335923 [TBL] [Abstract][Full Text] [Related]
6. Tumor cell cytotoxicity of a novel metal chelator. Torti SV; Torti FM; Whitman SP; Brechbiel MW; Park G; Planalp RP Blood; 1998 Aug; 92(4):1384-9. PubMed ID: 9694727 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and potent antitumor activities of novel 1,3,5-cis,cis-triaminocyclohexane N-pyridyl derivatives. Chong HS; Torti SV; Ma R; Torti FM; Brechbiel MW J Med Chem; 2004 Oct; 47(21):5230-4. PubMed ID: 15456266 [TBL] [Abstract][Full Text] [Related]
8. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334 [TBL] [Abstract][Full Text] [Related]
9. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151 [TBL] [Abstract][Full Text] [Related]
10. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Zhao R; Planalp RP; Ma R; Greene BT; Jones BT; Brechbiel MW; Torti FM; Torti SV Biochem Pharmacol; 2004 May; 67(9):1677-88. PubMed ID: 15081867 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of copper chelation agents as anti-angiogenic therapy. Camphausen K; Sproull M; Tantama S; Sankineni S; Scott T; Ménard C; Coleman CN; Brechbiel MW Bioorg Med Chem; 2003 Sep; 11(19):4287-93. PubMed ID: 12951159 [TBL] [Abstract][Full Text] [Related]
13. In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bass LA; Wang M; Welch MJ; Anderson CJ Bioconjug Chem; 2000; 11(4):527-32. PubMed ID: 10898574 [TBL] [Abstract][Full Text] [Related]
14. Copper(II) complexes of novel N-alkylated derivatives of cis,cis-1,3,5-triaminocyclohexane. 1. Preparation and structure. Park G; Shao J; Lu FH; Rogers RD; Chasteen ND; Brechbiel MW; Planalp RP Inorg Chem; 2001 Aug; 40(17):4167-75. PubMed ID: 11487319 [TBL] [Abstract][Full Text] [Related]
15. Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation. Kang CS; Wu N; Chen Y; Sun X; Bandara N; Liu D; Lewis MR; Rogers BE; Chong HS J Inorg Biochem; 2016 Jan; 154():60-6. PubMed ID: 26583705 [TBL] [Abstract][Full Text] [Related]
16. A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform. Baranyai Z; Reich D; Vágner A; Weineisen M; Tóth I; Wester HJ; Notni J Dalton Trans; 2015 Jun; 44(24):11137-46. PubMed ID: 25999035 [TBL] [Abstract][Full Text] [Related]
17. In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands. Sun X; Wuest M; Kovacs Z; Sherry AD; Motekaitis R; Wang Z; Martell AE; Welch MJ; Anderson CJ J Biol Inorg Chem; 2003 Jan; 8(1-2):217-25. PubMed ID: 12459917 [TBL] [Abstract][Full Text] [Related]
18. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652 [TBL] [Abstract][Full Text] [Related]
19. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals. Cai H; Li Z; Huang CW; Park R; Shahinian AH; Conti PS Nucl Med Biol; 2010 Jan; 37(1):57-65. PubMed ID: 20122669 [TBL] [Abstract][Full Text] [Related]
20. Novel hexadentate and pentadentate chelators for ⁶⁴Cu-based targeted PET imaging. Sin I; Kang CS; Bandara N; Sun X; Zhong Y; Rogers BE; Chong HS Bioorg Med Chem; 2014 Apr; 22(8):2553-62. PubMed ID: 24657050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]